RAPT Therapeutics Announces Late-Breaking Oral Presentation of Positive Results from Phase 1b Trial of RPT193 at the 30th European Academy of Dermatology and Venereology Congress
Benefit demonstrated in all key exploratory efficacy endpoints – EASI, EASI-50, EASI-75, EASI-90, vIGA, BSA…
Allcredit.cards Launches Comprehensive Database of 3,500 US Credit Cards